BLINN MARK A has demonstrated a clear selling bias in recent transactions, with no recorded purchases in the latest filings. Over 39 reported trades across five companies—primarily Texas Instruments (TXN), Globe Life (GL), and Emerson Electric (EMR)—his activity totals $1.8 million in buys against $3.78 million in sales, reflecting a net divestment trend. Notably, all 10 of his most recent transactions since January 2026 were sales or dispositions, including a $258,842 sale of GL shares on February 6 and combined EMR sales worth $438,929 on February 5. TXN has been a focal point, with a single $696,646 sale on February 5 accompanied by multiple smaller dispositions labeled as "M" (likely option exercises or awards).
Historical data shows larger TXN sales in prior years, including a $1.17 million transaction in February 2025, though recent activity has been more fragmented. The absence of buys since at least 2025, coupled with the acceleration of sales in early 2026, suggests a consistent reduction in holdings. While some transactions involve minor awards (coded "A" with $0 value), the dominant pattern is monetization, particularly in TXN and EMR. The dollar-weighted volume and frequency of sales indicate a strategic unwind rather than isolated adjustments.
AI-assisted summary